Pretreatment of mice with low quantities of LPS induces endotoxin tolerance characterized by enhanced resistance to lethal doses of LPS and to a number of infectious challenges. Mice subjected to cecal ligation and puncture (CLP) survived the ensuing septic peritonitis significantly better when they had been pretreated with LPS. This LPS-induced protection was dependent on endogenous TNF production capacity since LPS pretreatment did not protect TNF-deficient mice from death after CLP. While mice deficient in the TNF receptor type 2 (p75TNFR) were as sensitive to CLP-induced mortality as control mice, LPS pretreatment could not reduce mortality in p75TNFR-deficient mice after CLP. Therefore, activation of the TNF receptor type 2 by endogenous TNF constitutes an important interaction for the development of LPS-induced resistance to bacterial infection.
INTRODUCTION
Pretreatment of mice with low amounts of endotoxin (bacterial lipopolysaccharide, LPS) induces a so-called endotoxin tolerance. This immune status is characterized by protection of the host from a lethal LPS challenge. In addition, LPS-pretreated mice are protected against a number of bacterial infections, e.g. infection with Salmonella typhimurium, 1 polymicrobial challenges induced by cecal ligation and puncture (CLP) 2 or colon ascendens stent peritonitis (CASP). 3 A number of mechanisms have been proposed to explain this LPS-induced protection. Basically, two explanations present themselves: either LPS-pretreatment prepares the host organism by pre-activating antibacterial mechanisms of the innate immune system and/or it induces a counter-regulation of the hyperinflammatory state after infection. If an excessive inflammation results after bacterial infection, it could potentially damage the host organism and contribute to lethality. Pre-activation of monocytes/macrophages for a quick and strong antibacterial reaction (e.g. release of tumor necrosis factor [TNF], IL-1, IL-6, IL-12, production of reactive oxygen intermediates [ROI], enhanced phagocytosis, or stimulation of the hematopoetic system) could be counted among the preparatory mechanisms. Also, increased recruitment of neutrophilic granulocytes into the peritoneal cavity and enhanced phagocytic activity of the liver was observed after LPS pretreatment in the S. typhimurium model. 1 A LPS-induced diminished rate of apoptosis of neutrophils was suggested to account for the presence of increased cell numbers. 3 The idea of a beneficial effect of LPS pretreatment by counter-regulating the hyperinflammatory reaction came up when the pathological consequences of an overshooting release of inflammatory mediators like TNF were recognized. During endotoxin tolerance, LPS-induced TNF production is considerably reduced. 1 The reduced TNF production during endotoxin tolerance could be due to the fact that transcription of NF-mB-controlled genes like the TNF gene might be hampered because a non-functional NF-mB complex prevails in the nucleus after LPS pretreatment. 4 Also, the induction of antagonistic forms of mediators like IL-1 receptor antagonist (IL-1Ra) by LPS or shedding of TNF receptors which act as soluble competitive TNF-binding molecules counteract an on-going inflammatory response. Down-regulation of transmembrane molecules essential for signal transduction (e.g. TNF receptors or Toll-like receptors [TLR]) could equally contribute to a transient refractoriness of responder cells.
However, whether endogenous TNF production and function or changes of any of the above-mentioned parameters contribute to the observed LPS-induced protection from infection has not been investigated. By using mice with defective genes for TNF or the two TNF receptors (p55TNFR, p75TNFR) we found that LPS pretreatment-induced protection from lethal consequences after CLP was indeed dependent on TNF production and required the functional TNF receptor type 2 (p75TNFR).
MATERIALS AND METHODS

Mice
Mice of strain C57BL/6 were obtained from Charles River, Germany. Mice deficient in the p75TNFR (p75TNF -/-) 5 or for the p55TNFR (p55TNFR -/-) 6 had been backcrossed 6 times to C57BL/6 and were obtained from RCC, Füllinsdorf, Switzerland. TNF -/mice 7 and TNF +/+ mice which had been maintained in a mixed 129/Sv Z C57BL/6 genetic background were obtained from the GSF-Forschungszentrum, Munich, Germany. Mice used for the experiments were ageand sex-matched. All mice were fed with a standard diet, received water ad libitum and were kept in the animal facility of the University of Regensburg according to institutional guidelines and in accordance with the German law for animal experimentations.
Cecal ligation and puncture (CLP)
Mice were anesthetized by i.p. injection of 75 mg/kg Ketanest (Parke, Davis & Company, Munich, Germany) and 16 mg/kg Rompun (Bayer AG, Leverkusen, Germany) in 0.2 ml sterile pyrogen-free saline (Fresenius AG, Bad Homburg, Germany). The cecum was exteriorized and the distal end of the cecum (70% of its length) was ligated and punctured twice with a 0.9 mm needle as described previously. 8 Mice were observed for 2 weeks.
LPS pretreatment
For pretreatment with LPS, mice were injected i.p. with 10 mg LPS per mouse 24 h before CLP. LPS W from Salmonella minnesota 9700 was purchased from Difco Laboratories, Detroit, MI, USA.
Statistical methods
Kaplan Meier survival curves were compared using the log rank test.
RESULTS
Protection by LPS pretreatment
In order to check whether LPS-induced protection from CLP-induced lethality is TNF-dependent, TNF-deficient (TNF -/-) mice were pretreated with 10 mg LPS and 24 h later a lethal CLP was performed. Mice competent for TNF production survived significantly better than TNF -/mice ( Fig. 1) . Also, when a milder course of septic peritonitis was generated by ligation of a shorter end of the cecum, a significantly better protection was induced in TNF +/+ than in TNF -/mice, demonstrating that endogenous TNF production is also critical for LPSinduced resistance after a less lethal CLP measure (data not shown).
Role of TNF receptors for survival after CLP
The role of the TNF receptors for survival after CLP had to be investigated before the involvement of the two TNF receptors in LPS-induced protection could be investigated in this infection model. For this purpose, p55TNFR-deficient mice (p55TNFR -/-) were subjected to a sublethal CLP and survival was compared to control mice with a functional p55TNFR gene in the same genetic background. No p55TNFR -/mouse survived the sublethal CLP, whereas, 5 out of 6 control mice survived (Fig. 2) , indicating the important function of the p55TNFR for efficiently combating septic peritonitis. In contrast, no significant difference in survival was observed between mice lacking the p75TNFR or control mice after sublethal CLP (data not shown). This was likewise the case when the severity of CLP was increased, leading to higher mortality (Fig. 3) .
Effect of LPS pretreatment in TNFR-deficient mice
To test whether this clear dependency of survival on the p55TNFR after CLP was also valid for LPS-induced protection from CLP-induced lethality, p55TNFR -/mice were pretreated with 10 mg LPS; 24 h later, CLP was performed which was lethal for p55TNFR -/as well as for control mice. Surprisingly, this pretreatment improved survival of both p55TNFR -/and normal mice to a similar extent ( Fig. 4) , indicating that TNF action on the p75TNFR is sufficient for the LPS-induced protection from CLP-induced lethality. To test this, p75TNFR -/mice and control mice were pretreated with 10 mg LPS followed by a lethal CLP 24 h later. While control mice were protected by LPS pretreatment, p75TNFR -/mice could not be protected (Fig. 5 ).
Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis 367
Hours after CLP
DISCUSSION
The capacity to react to LPS does not seem to be decisive for defense against intestinal bacterial spreading after CLP. Survival after CLP was not influenced by the lack of LBP or TLR4, 9 two molecules clearly involved in LPS-binding and signalling. 10, 11 Obviously, the many TLR4-independent ways to activate the innate immune system compensate for the absent LPS signalling in this peritonitis model with mixed bacterial infection.
Most of the known TNF effects depend on the activation of the TNFR type 1 (p55TNFR). Early on, it became clear that TNF is an important factor in bacterial infections and essential for survival after CLP (Echtenacher et al. 8 and this study). Exogenous TNF can even be used to protect mice from the lethal effects of CLP. 12 P55TNFR-deficient mice have been shown to be protected from LPS-induced shock in galactosamine-sensitized mice, 6 demonstrating that the action of LPS-induced endogenous TNF via the p55TNFR accounts for the observed hepatotoxicity. The presence of the death domain in the intracellular part of the p55TNFR leading to apoptotic death of the hepatocytes provides the molecular explanation for the cytotoxic effector mechanism of TNF. 13 On the other hand, activation of monocytes/macrophages and other cells of the innate immune system are induced by TNF via the p55TNFR leading to production and release of antibacterial substances. 14 Survival of mice after CLP clearly depends on the p55TNFR as shown in this study. In addition, survival of p55TNFR -/mice was reduced after infection with Escherichia coli i.p. 15 or Listeria monocytogenes, 6 demonstrating the important function of the TNF activation of the p55TNFR for host defense in bacterial infections.
The function of the p75TNFR is less well understood. Besides the supportive action of the p75TNFR for p55TNFR signaling, only few effects are solely attributed to the p75TNFR. Mice deficient for the p75TNFR do not exhibit an obvious phenotype besides being less sensitive to high-dose LPS toxicity, 6 TNF-induced skin necrosis, 5 hypersensitivity reactions, 16 and cerebral malaria. 17 Stimulation of thymocytes, 18 T-cells, 19 LAK cells, 20 and NK cells 21 has been reported to result after p75TNFR activation. Another direct TNF effect known to be mediated via the p75TNFR is the production of GM-CSF by thymocytes. 18 Such GM-CSF might recruit neutrophils into the peritoneal cavity, preparing the host for defense against intestinal bacteria. Removal of neutrophils or reducing their number by pretreatment with antiserum to G-CSF significantly lowered the survival rate after CLP. 22 Activation of NF-mB which is prominent after stimulation of the p75TNFR could also contribute to the mediation of the LPS-induced protection seen in this study. Since endogenous 26 kDa cell-associated TNF interacts preferentially with the p75TNFR, 23 such endogenous TNF produced after LPS treatment could interact with p75TNFR, thus leading to enhanced expression of NF-mB-dependent genes. Another not yet well analyzed possibility could be that LPS treatment induces a shift from production of membrane p75TNFR to the recently discovered splice variant of an intracellular p75TNFR isoform. 24 Activation of this intracellular p75TNFR leads to strong NF-mB activity and makes cells resistant to TNFinduced cytotoxicity (unpublished results). Whether and how this could contribute to enhanced resistance for a subsequent bacterial challenge is currently under investigation. By inducing NF-mB activation, this function of the p75TNFR certainly does not support the above-mentioned hypothesis that counter-regulation based on reduced expression of NF-mB-dependent genes could be the reason for the LPS-induced protection.
The results of this study clearly show that independently of how the endotoxin tolerance finally is achieved, the interaction of LPS-induced endogenously produced TNF with a product of the p75TNFR gene is required for the establishment of enhanced resistance to bacterial challenge as caused by CLP.
